MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Vial comparison
Compare MOTS-c research vials using the amount per vial and the number of vials in each selection. The index recognizes MOTSC and MOTS C as spelling variants.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Reported quantities in this family: 1, 2, 3, 5, 6, 10. Counts and units must be matched to the exact listing.
The current catalog includes 5 mg, 10 mg, 20 mg and 40 mg labels, along with other stated amounts. Select an exact amount to compare equal selections, or use price per mg to examine size differences. A lower unit price can still come with a larger upfront total cost.
Read the complete product title when a result includes MOTS-c. The catalog also contains combinations labeled NAD+ / MOTS-C / 5-Amino-1MQ. Those are separate blend listings; their total weight cannot be used as the amount of MOTS-c alone.
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 5 mg | 1 vial | $54.99 | $11.00 | 1 | Compare |
| 10 mg | 1 vial | $20.34 | $2.03 | 40 | Compare |
| 13.5 mg | 1 vial | $21.99 | $1.63 | 1 | Compare |
| 20 mg | 1 vial | $44.10 | $2.21 | 9 | Compare |
| 40 mg | 1 vial | $54.00 | $1.35 | 19 | Compare |
| 44.5 mg | 1 vial | $86.34 | $1.94 | 1 | Compare |

122 products · 249 listings

153 products · 275 listings

20 products · 27 listings

44 products · 56 listings

23 products · 62 listings
26 products · 27 listings

15 products · 20 listings

35 products · 36 listings

25 products · 25 listings

32 products · 41 listings

4 products · 4 listings

20 products · 34 listings

29 products · 143 listings

11 products · 64 listings

36 products · 58 listings

34 products · 51 listings

44 products · 62 listings

42 products · 96 listings

22 products · 36 listings

29 products · 39 listings

5 products · 12 listings

24 products · 29 listings

38 products · 79 listings

43 products · 57 listings

20 products · 30 listings

23 products · 26 listings

27 products · 105 listings

40 products · 50 listings

33 products · 135 listings
28 products · 30 listings

19 products · 24 listings

26 products · 58 listings

19 products · 25 listings

35 products · 40 listings
34 products · 47 listings

41 products · 52 listings

32 products · 43 listings

37 products · 56 listings
22 products · 29 listings

35 products · 45 listings

16 products · 27 listings

38 products · 47 listings

50 products · 65 listings

39 products · 51 listings

31 products · 35 listings

29 products · 46 listings

18 products · 66 listings

37 products · 58 listings

38 products · 72 listings

30 products · 49 listings
15 listings from direct supplier captures and 98 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
These spelling variants are grouped together for search and comparison. The original source still determines the labeled amount, pack count and product details for each offer.
An aggregator capture shows when we obtained its data. Even an upstream catalog update does not prove when that supplier's specific price or stock was last checked. Open the vendor source to confirm the current listing.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame hidden inside the 12S ribosomal RNA gene of mitochondrial DNA, first described in 2015 by Changhan Lee and Pinchas Cohen's group at the University of Southern California. In mice it activates AMPK, improves insulin sensitivity, prevents diet-induced obesity and, when given to old animals, improves running capacity and healthspan, and in young men its plasma level rises after a bout of cycling; it is sold online as an exercise mimetic on the strength of that work. No human trial of MOTS-c itself has been completed: a related analog, CB4211, finished a phase 1a/1b study in 2021 before its developer dissolved, and a phase 2a trial of MOTS-c in prediabetes began recruiting in 2026. WADA prohibits it at all times as an AMPK activator (S4.4.1), and the FDA listed it among compounding substances that may present significant safety risks from 2023 until the nomination was withdrawn in April 2026, noting that it had found no human exposure data at all.
The foundational Cell Metabolism study reported effects in diet- and age-related mouse models.
Mechanistic work links MOTS-c to cellular metabolic stress responses.
Reviews emphasize that therapeutic human evidence remains limited and clinical development is ongoing.
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.